2167 related articles for article (PubMed ID: 19250787)
1. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
Stubenrauch K; Wessels U; Lenz H
J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
[TBL] [Abstract][Full Text] [Related]
3. Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samples.
Stubenrauch K; Wessels U; Essig U; Kowalewsky F; Vogel R; Heinrich J
J Pharm Biomed Anal; 2013 Jan; 72():208-15. PubMed ID: 23017233
[TBL] [Abstract][Full Text] [Related]
4. Quantitative determination of humanized monoclonal antibody rhuMAb2H7 in cynomolgus monkey serum using a Generic Immunoglobulin Pharmacokinetic (GRIP) assay.
Yang J; Ng C; Lowman H; Chestnut R; Schofield C; Sandlund B; Ernst J; Bennett G; Quarmby V
J Immunol Methods; 2008 Jun; 335(1-2):8-20. PubMed ID: 18402977
[TBL] [Abstract][Full Text] [Related]
5. Species-dependent serum interference in a sandwich ELISA for Apo2L/TRAIL.
DeForge LE; Shih DH; Kennedy D; Totpal K; Chuntharapai A; Bennett GL; Drummond JH; Siguenza P; Wong WL
J Immunol Methods; 2007 Mar; 320(1-2):58-69. PubMed ID: 17280683
[TBL] [Abstract][Full Text] [Related]
6. Does exposure to swine leukocyte antigens after pig-to-nonhuman primate xenotransplantation provoke antibodies that cross-react with human leukocyte antigens?
Key T; Schuurman HJ; Taylor CJ
Xenotransplantation; 2004 Sep; 11(5):452-6. PubMed ID: 15303982
[TBL] [Abstract][Full Text] [Related]
7. A quantitative human monoclonal antibody immunoassay using anti-idiotypic antibody as a membrane antigen surrogate with surface-plasmon-resonance detection.
Wong RB; Lee AH; Rangan VS; Cheng KC
Biotechnol Appl Biochem; 2009 May; 53(Pt 1):51-61. PubMed ID: 18680480
[TBL] [Abstract][Full Text] [Related]
8. Development and optimization of a cell-based neutralizing antibody assay using a sample pre-treatment step to eliminate serum interference.
McCutcheon KM; Quarmby V; Song A
J Immunol Methods; 2010 Jun; 358(1-2):35-45. PubMed ID: 20361968
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel homogenous electrochemiluminescence assay for quantitation of ranibizumab in human serum.
Lowe J; Maia M; Wakshull E; Siguenza P; Liu P; Lakhani S; Rusit J; Elliott R; Quarmby V
J Pharm Biomed Anal; 2010 Sep; 52(5):680-6. PubMed ID: 20226615
[TBL] [Abstract][Full Text] [Related]
10. Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry.
Li J; Schantz A; Schwegler M; Shankar G
J Pharm Biomed Anal; 2011 Jan; 54(2):286-94. PubMed ID: 20869832
[TBL] [Abstract][Full Text] [Related]
11. Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA.
Smith HW; Butterfield A; Sun D
Regul Toxicol Pharmacol; 2007 Dec; 49(3):230-7. PubMed ID: 17869396
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of immunoassays to quantify the half-antibody exchange of an IgG4 antibody, natalizumab (Tysabri®) with endogenous IgG4.
Shapiro RI; Plavina T; Schlain BR; Pepinsky RB; Garber EA; Jarpe M; Hochman PS; Wehner NG; Bard F; Motter R; Yednock TA; Taylor FR
J Pharm Biomed Anal; 2011 Apr; 55(1):168-75. PubMed ID: 21300512
[TBL] [Abstract][Full Text] [Related]
13. Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.
St Ledger K; Agee SJ; Kasaian MT; Forlow SB; Durn BL; Minyard J; Lu QA; Todd J; Vesterqvist O; Burczynski ME
J Immunol Methods; 2009 Oct; 350(1-2):161-70. PubMed ID: 19732777
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody-based immunoenzymetric assays for quantification of human IgG and its four subclasses.
Hamilton RG; Wilson RW; Spillman T; Roebber M
J Immunoassay; 1988; 9(3-4):275-96. PubMed ID: 3069872
[TBL] [Abstract][Full Text] [Related]
15. A one-step, competitive electrochemiluminescence-based immunoassay method for the quantification of a fully human anti-TNFalpha antibody in human serum.
Horninger D; Eirikis E; Pendley C; Giles-Komar J; Davis HM; Miller BE
J Pharm Biomed Anal; 2005 Jul; 38(4):703-8. PubMed ID: 15967298
[TBL] [Abstract][Full Text] [Related]
16. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.
Zahorsky-Reeves JL; Kearns-Jonker MK; Lam TT; Jackson JR; Morris RE; Starnes VA; Cramer DV
Xenotransplantation; 2007 Mar; 14(2):135-44. PubMed ID: 17381688
[TBL] [Abstract][Full Text] [Related]
17. Generic anti-drug antibody assay with drug tolerance in serum samples from mice exposed to human antibodies.
Stubenrauch K; Mackeben K; Vogel R; Heinrich J
Anal Biochem; 2012 Nov; 430(2):193-9. PubMed ID: 22935295
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a peptide ELISA for the detection of rituximab in serum.
Blasco H; Lalmanach G; Godat E; Maurel MC; Canepa S; Belghazi M; Paintaud G; Degenne D; Chatelut E; Cartron G; Le Guellec C
J Immunol Methods; 2007 Aug; 325(1-2):127-39. PubMed ID: 17651747
[TBL] [Abstract][Full Text] [Related]
19. Reduction of matrix interferences by the combination of chaotropic salt and DMSO in a broadly applicable target-based ELISA for pharmacokinetic studies of therapeutic monoclonal antibodies.
Doucet J; Canadi J; Kalis C; Valentin MA; Marrony S; Deckert-Salva F; Legay F; Avrameas A
J Pharm Biomed Anal; 2009 Dec; 50(5):924-31. PubMed ID: 19608373
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
Welfringer F; d'Athis P; Scherrmann JM; Hervé F
J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
